BROMOCRIPTINE AND DOMPERIDONE IN THE TREATMENT OF PARKINSON DISEASE

被引：55

作者：

QUINN, N ^{[1
]}

ILLAS, A ^{[1
]}

LHERMITTE, F ^{[1
]}

AGID, Y ^{[1
]}

机构：

[1] HOP SALPETRIERE,NEUROL & NEUROPSYCHOL CLIN,F-75634 PARIS 13,FRANCE

来源：

NEUROLOGY | 1981年 / 31卷 / 06期

关键词：

D O I：

10.1212/WNL.31.6.662

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：662 / 667

页数：6

共 19 条

[1] BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING-AGENT IN TREATMENT OF PARKINSONS-DISEASE [J].

AGID, Y ;

BONNET, AM ;

POLLAK, P ;

SIGNORET, JL ;

LHERMITTE, F .

LANCET, 1979, 1 (8116) :570-572

[2]

BOGAERTS M, 1979, POSTGRAD MED J, V55, P51

[3] BROMOCRIPTINE IN PARKINSONISM [J].

CALNE, DB ;

TEYCHENNE, PF ;

CLAVERIA, LE ;

EASTMAN, R ;

GREENACRE, JK ;

PETRIE, A .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444

[4]

CALNE DB, 1978, LANCET, V1, P735

[5]

CORSINI GU, 1979, LANCET, V1, P954

[6]

Debono A G, 1975, Lancet, V2, P987

[7]

FAHN S, 1978, NEUROLOGY, V28, P343

[8] EFFECT OF CB-154 (2-BROMO-ALPHA-ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE-BLIND, CROSSOVER TRIAL [J].

GERLACH, J .

ACTA NEUROLOGICA SCANDINAVICA, 1976, 53 (03) :189-200

[9] COMPARISON OF EFFECTS OF BROMOCRIPTINE AND LEVODOPA IN PARKINSONS-DISEASE [J].

GODWINAUSTEN, RB ;

SMITH, NJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (05) :479-482

[10] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

← 1 2 →